AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA signals expedited review for antibody

5th January 2023 Uncategorised 0

AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA signals expedited review for antibody
aliu
Thu, 01/05/2023 – 10:13

More: AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA signals expedited review for antibody
Source: fierce